Aspen Pharmacare Holdings Limited

(PINK:APNHF)

Latest On Aspen Pharmacare Holdings Limited (APNHF):

Date/Time Type Description Signal Details
2023-09-21 06:04 ESTDividendA dividend of $3.42 has been announced on Aug 30, 2023. It will be paid Sep 26, 2023 with an ex-dividend date of Sep 21, 2023.Neutral
2023-03-04 06:38 ESTNewsAspen Pharmacare Holdings GAAP EPS of $0.60, revenue of $19.15BN/A
2023-03-03 02:04 ESTNewsAspen Pharmacare Holdings Limited (APNHF) H1 2023 Earnings Call TranscriptN/A
2023-03-02 11:12 ESTNewsAspen Pharmacare Holdings Limited 2023 Q2 - Results - Earnings Call PresentationN/A
2022-09-22 06:08 ESTDividendA dividend of $3.26 has been announced on Aug 31, 2022. It will be paid Sep 26, 2022 with an ex-dividend date of Sep 22, 2022.Neutral
2022-09-02 09:58 ESTNewsAspen Pharmacare Holdings GAAP EPS of R$14.32, revenue of R$38.61BN/A
2022-09-01 16:45 ESTNewsAspen Pharmacare Holdings Limited (APNHF) Q4 2022 Earnings Call TranscriptN/A
2022-08-31 23:46 ESTNewsAspen inks deal with India’s Serum Institute to introduce four vaccines for AfricaN/A
2022-08-11 04:01 ESTNewsJohnson & Johnson partner Aspen risks closure of COVID vaccine plant as orders dry upN/A
2022-03-11 04:52 ESTNewsAspen Pharmacare Holdings Limited 2022 Q2 - Results - Earnings Call PresentationN/A
2022-03-11 04:52 ESTNewsAspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Interim 2022 Results - Earnings Call TranscriptN/A
2022-03-09 17:38 ESTNewsAspen Pharmacare Holdings reports 1H resultsN/A
2022-03-09 00:38 ESTNewsJohnson & Johnson inks deal with Aspen as COVID-19 vaccine makers focus on AfricaN/A
2021-09-22 06:13 ESTDividendA dividend of $2.62 has been announced on Sep 1, 2021. It will be paid Sep 27, 2021 with an ex-dividend date of Sep 22, 2021.Neutral
2021-09-09 17:28 ESTNewsAspen Pharmacare hits 52-week high after unsolicited offers for pharma ingredient unitN/A
2021-09-03 07:58 ESTNewsAspen Pharmacare Holdings Limited 2021 Q4 - Results - Earnings Call PresentationN/A
2021-09-03 07:58 ESTNewsJohnson & Johnson vaccine shipments from Africa to Europe on holdN/A
2021-09-02 12:00 ESTNewsAspen Pharmacare Holdings reports FY resultsN/A
2021-09-02 12:00 ESTNewsAspen Pharmacare posts higher FY topline, shares riseN/A
2021-09-02 12:00 ESTNewsAspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Q4 2021 Results - Earnings Call TranscriptN/A
2021-09-01 16:10 ESTNewsJohnson & Johnson in talks with Aspen Pharmacare for a licensing deal for COVID-19 shotN/A
2021-03-13 12:42 ESTNewsAspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad Presents H1 2021 Results at JP Morgan Healthcare Conference (Transcript)N/A
2021-03-13 09:40 ESTFinancialsCompany financials have been released.Neutral
2020-12-04 18:18 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 23:38 ESTFinancialsCompany financials have been released.Neutral
2020-11-08 02:34 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 18:54 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 15:46 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 08:11 ESTFinancialsCompany financials have been released.Neutral
2020-09-11 06:33 ESTFinancialsCompany financials have been released.Neutral
2020-09-10 13:53 ESTNewsAspen Pharmacare Holdings beats on revenueN/A
2020-09-10 13:53 ESTNewsAspen Pharmacare Holdings Limited (APNHF) CEO Stephen Saad on Q4 2020 Results - Earnings Call TranscriptN/A
2020-08-31 08:00 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 11:49 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 15:27 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 19:37 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 07:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-29 23:49 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 17:11 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 15:26 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 20:17 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 11:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 19:19 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 03:09 ESTFinancialsCompany financials have been released.Neutral
2020-06-19 15:12 ESTFinancialsCompany financials have been released.Neutral
2020-06-14 07:22 ESTFinancialsCompany financials have been released.Neutral
2020-06-12 08:55 ESTFinancialsCompany financials have been released.Neutral
2020-05-27 08:00 ESTFinancialsCompany financials have been released.Neutral
2020-05-21 03:40 ESTFinancialsCompany financials have been released.Neutral
2020-05-06 08:18 ESTFinancialsCompany financials have been released.Neutral

About Aspen Pharmacare Holdings Limited (APNHF):

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anaesthetics and muscle relaxants under the Anaesthetics brand; cytotoxic medicines under the Regional brand; and injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It is also involved in the contract and supply of chemical and biochemical active pharmaceutical ingredients and finished dose form pharmaceuticals for third parties. The company offers products in the form of oral solid dose, injectables, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

APNHF Quotes by TradingView

See Advanced Chart

General

  • Name Aspen Pharmacare Holdings Limited
  • Symbol APNHF
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 9,069
  • Last Split Factor1:3
  • Last Split Date2016-04-19
  • Fiscal Year EndJune
  • Web URLhttp://www.aspenpharma.com
View More

Valuation

  • Trailing PE 9.77
  • Price/Sales (Trailing 12 Mt.) 1.69
  • Price/Book (Most Recent Quarter) 0.94
  • Enterprise Value Revenue 0.18
  • Enterprise Value EBITDA 0.78
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Profit Margin 11%
  • Return on Assets 5%
  • Return on Equity 8%
  • Earnings Per Share $0.97
  • Revenue Per Share $0
  • Gross Profit 19.32 billion
  • Quarterly Earnings Growth 16.6%
View More

ESG Rating

  • Rating Date 2019-01-01
  • ESG Score 34.59
  • Environment Score 4.03
  • Social Score 21.36
  • Governance Score 16.71
  • Controversy Level 3
View More

Highlights

  • Market Capitalization 4.51 billion
  • Book Value Per Share $8.11
View More

Share Statistics

  • Shares Outstanding 455.52 million
  • Shares Float 371.75 million
  • % Held by Insiders 1562%
  • % Held by Institutions 57.9%
View More

Technicals

  • Beta 0.86
  • 52 Week High $10.5
  • 52 Week Low $6.39
  • 50 Day Moving Average 9.67
  • 200 Day Moving Average 8.26
View More

Dividends

  • Dividend Date 2017-10-09
  • ExDividend Date 2018-10-04
  • Dividend Per Share $0.23
  • Dividend Yield 0%
View More

Aspen Pharmacare Holdings Limited (APNHF) Dividend Calendar:

APNHF's last dividend payment was made to shareholders on October 9, 2017.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2023-09-212023-09-262023-09-222023-08-30$3.42
2022-09-222022-09-262022-09-232022-08-31$3.26
2021-09-222021-09-272021-09-232021-09-01$2.62
2018-10-042018-10-082018-10-052018-09-13$3.15
2017-10-052017-10-092017-10-062017-09-14$2.87
2016-10-062016-10-102016-10-072016-09-14$2.48

Aspen Pharmacare Holdings Limited (APNHF) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-12-31$N/A$0.17$0.00
2020-06-302020-09-30$N/A$0.15$0.00
2020-03-312020-06-30$N/A$0.14$0.00
2019-12-312020-03-31$9.21 billion$0.13$0.00
2019-09-302019-12-31$9.21 billion$0.19$0.00
2019-06-302019-09-30$9.6 billion$0.18$0.00
2018-09-302018-12-31$9.84 billion$0.20$0.00
2018-06-302018-09-30$10.35 billion$0.21$0.00
2018-03-312018-06-30$10.35 billion$0.18$0.00
2017-12-312018-03-31$10.95 billion$0.20$0.00
2017-09-302017-12-31$10.95 billion$0.30$0.00
2017-06-302017-09-30$8.25 billion$0.28$0.00
2017-03-312017-06-30$8.04 billion$0.19$0.00
2016-12-312017-03-31$9.9 billion$0.19$0.00
2016-09-302016-12-31$9.9 billion$0.22$0.00
2016-06-302016-09-30$0.22$0.00
2016-03-312016-06-30$0.07$0.00
2015-12-312016-03-31$0.07$0.00
2015-09-302015-12-31$0.24$0.00
2015-06-302015-09-30$0.26$0.00
2015-03-312015-06-30$0.25$0.00
2014-12-312015-03-31$0.25$0.00
2014-09-302014-12-31$0.23$0.00
2014-06-302014-09-30$0.24$0.00
2014-03-312014-06-30$0.32$0.00
2013-12-312014-03-31$0.32$0.00
2013-09-302013-12-31$0.20$0.00
2013-06-302013-09-30$0.21$0.00
2013-03-312013-06-30$0.20$0.00
2012-12-312013-03-31$0.22$0.00
2012-09-302012-12-31$0.22$0.00
2012-06-302012-09-30$0.22$0.00
2011-09-302011-12-31$0.18$0.00
2011-06-302011-09-30$0.18$0.00
2011-03-312011-06-30$0.17$0.00
2010-12-312011-03-31$0.17$0.00
2010-09-302010-12-31$0.19$0.00

Aspen Pharmacare Holdings Limited (APNHF) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Aspen Pharmacare Holdings Limited (APNHF) Chart:

Aspen Pharmacare Holdings Limited (APNHF) News:

Below you will find a list of latest news for Aspen Pharmacare Holdings Limited (APNHF) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Aspen Pharmacare Holdings Limited (APNHF) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Aspen Pharmacare Holdings Limited (APNHF) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2009-01-16F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1454177/000101915509000061/0001019155-09-000061-index.htm
2012-07-18F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/1454177/000101915512000447/0001019155-12-000447-index.htm
2014-01-28F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1454177/000119380514000129/0001193805-14-000129-index.htm
2015-04-27F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1454177/000119380515000640/0001193805-15-000640-index.htm
2015-08-27F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1454177/000119380515001424/0001193805-15-001424-index.htm
2017-09-29F-6 POSPost-effective amendments for immediately effective filinghttps://www.sec.gov/Archives/edgar/data/1454177/000119380517003036/0001193805-17-003036-index.htm
2019-11-22F-6EFRegistration of American Depository Receipt shares, immediately effectivehttps://www.sec.gov/Archives/edgar/data/1454177/000119380519001743/0001193805-19-001743-index.htm